Azoy Alexander reported option exercise involving 2,827 shares of Arcus Biosciences, Inc. at $15.44 for $43.6k on Aug 21, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Accounting Officer
Chief Accounting Officer
Filed Aug 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$43,648.88Shares × reported price
Shares traded
2,827Common Stock
Price per share
$15.44Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
42,408Direct
Trade date
Aug 21, 2026Option exercise
Filed
Aug 24, 2026, 5:52 PM ET3-day reporting delay
Accession
0001771961-26-000006Code M · Transaction 84996
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 21, 2026Sell2,827$30.00−$84,810Trade 84997
Aug 21, 2026Option exercise2,827$0.00$0Trade 84998
3 transaction rows in this filing. Joint filers share the same rows.

RCUS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RCUS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.5%1w ago −2.1%1d ago −2%
Returns since7d −2.8%30d −12%90d180d1y

Footnotes in full

F1: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2: Includes the unvested portion of the Reporting Person's RSU grants. F3: The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company.